Richard Grondin

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

Navin Maswood, Jennifer Young, Edward M. Tilmont et al. · Proceedings of the National Academy of Sciences · 2004 · 384 citations · Full text

Motor Dysfunction, Caloric Restriction, Social Sciences +17

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

Richard Grondin, Zhiming Zhang, Ai Yi et al. · Brain · 2002 · 282 citations · Full text

Social Sciences, Neuroregeneration, Neurology +17

Point source concentration of GDNF may explain failure of phase II clinical trial

Michael F. Salvatore, Yi Ai, B FISCHER et al. · Experimental Neurology · 2006 · 257 citations

Therapeutic Drug Monitoring, Pharmacology, Clinical Trials +5

Antiparkinsonian effect of a new selective adenosine A_2Areceptor antagonist in MPTP-treated monkeys

Richard Grondin, P.J. Bédard, Abdallah Hadj Tahar et al. · Neurology · 1999 · 247 citations

Chronic Alterations in Dopaminergic Neurotransmission Produce a Persistent Elevation of ΔFosB‐like Protein(s) in both the Rodent and Primate Striatum

J. P. Doucet, Yusaku Nakabeppu, P.J. Bédard et al. · European Journal of Neuroscience · 1996 · 183 citations